TP53 and myelodysplastic syndrome: Analyzing patients with de novo MDS exhibiting fibrosis (MDS-F) revealed high p53 expression, accompanied by higher BM blast counts, alterations of chromosomes 5 or 7, CK, high- and very-high risk IPSS-R groups, TP53 mutations, and shorter OS [566, 567].